|
|
Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China
publication date: Dec 6, 2011
 Merck announced plans to build an Asia Research & Development headquarters in Beijing, which will be devoted to innovative drug discovery and development. The new initiative is part of a broader $1.5 billion investment in China R&D that Merck will make over the next five years. Merck said the investment has two goals: building its own capabilities and fostering relationships with outside researchers. It expects the center to provide new drugs and vaccines that meet global needs. More details.... Stock Symbol: (NYSE: MRK) Share this with colleagues:
This article is available for purchase - please click here for details.
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
Biosimilars Asia 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors Official Partners Supporting Partners Media Partners ![]()
|